期刊文献+

二吡唑铝化合物双光子吸收性质的理论研究 被引量:2

Theoretical Study on the Two-Photon Absorption Properties of Pyrazole Aluminum Compounds
下载PDF
导出
摘要 应用密度泛函理论(DFT)和半经验的ZINDO方法对二吡唑铝化合物的单、双光子吸收(OPA、TPA)性质进行了研究.结果表明,铝氮烷杂环化合物具有好的双光子吸收性质,其双光予最大吸收截面值(σ_(max))可达到2860.1 GM(1 GM=10^(-50)cm^4·s·photon^(-1)).在中心、共轭桥和末端引入强的吸电子基团可调谐单、双光子吸收光谱,实现在不同波长范围的双光子吸收;利用三态公式分析了分子的双光子吸收截面变化的内在原因;铝氮烷杂环化合物与其相应的硼化合物相比,表现出类似的单、双光子吸收性质,但一定程度上可增大双光子吸收截面. An extensive series of pyrazole aluminum compounds containing an AI2N4 center as a pseudo- conjugated system were theoretically investigated for their one-photon absorption and two-photon absorption (OPA and TPA) properties by density functional theory (DFT) and Zerner's intermediate neglect of differential overlap (ZINDO) methods. The results indicate that pyrazole aluminum compounds are good TPA materials and that the TPA maximal absorption cross-section (δmax) can reach 2860.1 GM (1GM=10^-50cm^4.s.photon^-1). By incorporating electron-acceptors in the central core, a n-conjugated bridge and terminal groups, the OPA and TPA properties can be modulated. This research provides strategies for the enhancement of molecular TPA in the target region. The origin of the large δmax of some of the studied molecules was determined using a three-level energy model. We conclude that an increase in the intramolecular charge transfer can enhance δmax. Moreover, the pyrazole aluminum compounds behave in a similar manner to pyrazabole chromophores in terms of linear optical, and TPA properties and they possess an increased δmax to some extent.
出处 《物理化学学报》 SCIE CAS CSCD 北大核心 2011年第10期2303-2310,共8页 Acta Physico-Chimica Sinica
基金 国家自然科学基金(20673045,20973078) 留学回国人员启动基金(外交司留(2008)890号) 国家重点基础研究发展计划项目(973)(2002CBN613406)资助~~
关键词 密度泛函理论:双光子吸收:双光子吸收截面 二吡唑铝:分子内电荷转移 Density functional theory Two-photon absorption Two-photon absorption cross-section Pyrazole aluminum Intramolecular charge transfer
  • 相关文献

参考文献2

二级参考文献37

  • 1Kanis, D. R.; Ratner, M. A.; Marks, T. J. Chem. Rev. 1994, 94, 195.
  • 2Dvornikov, A. S.; Rentzepis, P. M. Opt. Commun. 1995. 119, 341.
  • 3Cumpston, B. H.; Ananthavel, S. P.; Barlow, S.; Dyer, D. L.; Ehrlich, J. E.; Erskine, L. L.; Heikal, A. A.; Kuebler, S. M.; Lee, I.-Y. S.; McCord-Maughon, D.; Qin, J.; Rockel, H.; Rumi, M.; Wu, X.-L.; Marder, S. R.; Perry, J. W. Nature 1999, 398, 51.
  • 4Denk, W.; Svoboda, K. Neuron 1997, 18, 351.
  • 5Allain, C.; Schmidt, F.; Lartia, R.; Bordeau, G.; Fiorini- Debuisschert, C.; Charra, F.; Tauc, P.; Teulade-Fichou, M.-P. ChemBioChem 21107, 8, 424.
  • 6Fleitz, P. A.; Brant, M. C.; Sutherland, R. L.; Larson, F. P.; Dalton, L. R. SPIEProc. 1998, 3472, 91.
  • 7Ehrlich, J. E.; Wu, X. L.; Lee, I.-Y. S.; Hu, Z.-Y.; Roeckel, H.;Marder, S. R.; Perry, J. W. Opt. Lett. 1997, 22, 1843.
  • 8Bhawalkar, J. D.; He, G. S.; Prasad, P. N. Rep. Prog. Phys. 1996, 59, 1041.
  • 9Bhawalkar, J. D.; Kumar, N. D.; Zhao, C. F.; Prasad, P. N. J. Clin. Med. Surg. 1997, 37, 510.
  • 10Johnson, E.; Aroca, R.; Nagao, Y. J. Phys. Chem. 1991, 95, 8840.

共引文献24

同被引文献374

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部